Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
drugs
4
×
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
eli lilly
alder biopharmaceutical
alector
alkermes
allergan
american academy of neurology
amgen
atogepant
avrobio
baricitinib
What
new
4
×
drug
fda
approval
approved
arguments
big
bio
biopharma
cancer
cash
class
commercialized
committed
companies
competitors
congress
congressional
crispr
decades
deeper
deploy
dna
drugs
executives
far
feud
fingerprint
fund
genetic
going
group
hatteras
investments
isn’t
kicking
known
later
latest
launches
Language
Current search:
drugs
×
new
×
" raleigh-durham top stories "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues